Trial Profile
A single-blind, randomised, placebo-controlled, comparative induced pain model to investigate a topical gel combining methyl salicylate and menthol (SPR 300) in healthy volunteers
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 17 Nov 2014
Price :
$35
*
At a glance
- Drugs Menthol/methyl salicylate (Primary)
- Indications Pain
- Focus Adverse reactions
- 17 Nov 2014 New trial record